Literature DB >> 1911762

Study of a hammerhead ribozyme containing 2'-modified adenosine residues.

D B Olsen1, F Benseler, H Aurup, W A Pieken, F Eckstein.   

Abstract

The improved synthesis of 2'-fluoro-2'-deoxyadenosine (2'-FA) starting from adenosine is described. This compound was converted to the phosphoramidite and incorporated into a hammerhead ribozyme RNA with the use of automated RNA synthesis techniques. Ribozymes containing 2'-deoxy-adenosine (2'-dA) were prepared in a similar manner. A kinetic rate comparison of the unmodified ribozyme with two ribozymes that had every adenosine replaced with 2'FA or 2'-dA revealed a large decrease in catalytic efficiency (kcat/Km) for the modified ribozymes resulting from a drop in kcat. The kinetic analysis of a number of partially substituted 2'-FA or 2'-dA containing hammerheads revealed that the decrease in activity was not associated with any particular residue but was the result of the accumulation of modified nucleosides within the structure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911762     DOI: 10.1021/bi00104a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability.

Authors:  P Hendry; M J McCall; F S Santiago; P A Jennings
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

2.  Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2'-O-methylation.

Authors:  J Goodchild
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

3.  Importance of specific purine amino and hydroxyl groups for efficient cleavage by a hammerhead ribozyme.

Authors:  D J Fu; L W McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Ion-induced folding of the hammerhead ribozyme: a fluorescence resonance energy transfer study.

Authors:  G S Bassi; A I Murchie; F Walter; R M Clegg; D M Lilley
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

5.  Discrimination of a single base change in a ribozyme using the gene for dihydrofolate reductase as a selective marker in Escherichia coli.

Authors:  S Fujita; T Koguma; J Ohkawa; K Mori; T Kohda; H Kise; S Nishikawa; M Iwakura; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Selection, design, and characterization of a new potentially therapeutic ribozyme.

Authors:  Shawn P Zinnen; Kristal Domenico; Mike Wilson; Brent A Dickinson; Amber Beaudry; Victor Mokler; Andrew T Daniher; Alex Burgin; Leonid Beigelman
Journal:  RNA       Date:  2002-02       Impact factor: 4.942

Review 7.  Ribozymes: biology, biochemistry, and implications for clinical medicine.

Authors:  M Kiehntopf; E L Esquivel; M A Brach; F Herrmann
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

8.  Probing the hammerhead ribozyme structure with ribonucleases.

Authors:  R A Hodgson; N J Shirley; R H Symons
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

9.  An oligodeoxyribonucleotide that supports catalytic activity in the hammerhead ribozyme domain.

Authors:  P Chartrand; S C Harvey; G Ferbeyre; N Usman; R Cedergren
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

10.  Translation of 2'-modified mRNA in vitro and in vivo.

Authors:  H Aurup; A Siebert; F Benseler; D Williams; F Eckstein
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.